Clinical Trial Update: Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is investigating fertility-sparing treatment for endometrial cancer guided by molecular classification, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Fudan University | Conditions: Endometrial Cancer, Fertility | Phase 2, Phase 3 | Status: RECRUITING